IMDX
Insight Molecular Diagnostics
IMDX
IMDX
95 hedge funds and large institutions have $201M invested in Insight Molecular Diagnostics in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.06% less ownership
Funds ownership: 3.15% → 3.09% (-0.06%)
38% less capital invested
Capital invested by funds: $323M → $201M (-$122M)
Holders
95
Holding in Top 10
2
Calls
$1.28M
Puts
$178K
Top Buyers
| 1 | +$2.69M | |
| 2 | +$2.17M | |
| 3 | +$2.04M | |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$979K |
| 5 |
D.E. Shaw & Co
New York
|
+$598K |
Top Sellers
| 1 | -$6M | |
| 2 | -$2.73M | |
| 3 | -$1.29M | |
| 4 |
PWP
Private Wealth Partners
Mill Valley,
California
|
-$861K |
| 5 |
Millennium Management
New York
|
-$841K |